0 results

Patient Corner

Last reference updates

  • 24 Jan 2017 - Drug Updates

Apremilast (Otezla▼): risk of psychiatric symptoms

Increased risk for depression and suicidality in apremilast users.

Read more
  • 23 Jan 2017 - Drug Updates

Direct-acting antivirals for chronic HCV (interferon-free): risk of hepatitis B reactivation

Co-infected patients require close monitoring.

Read more
  • 9 Nov 2016 - Drug Updates

Brimonidine gel (Mirvaso▼): reports of symptom exacerbation

New prescribing advice released for brimonidine topical gel

Read more
  • 16 Sep 2016 - Drug Updates

Levonorgestrel-containing emergency contraceptives: interaction with hepatic enzyme inducers

Concomitant CYP3A4 enzyme inducers reduce the efficacy of levonorgestrel

Read more
  • 16 Sep 2016 - Drug Updates

Idelalisib (Zydelig▼): updated safety information on risk of infection

Treatment recommendations for idelalisib have been updated following conclusion of safety review

Read more
  • 16 Sep 2016 - Drug Updates

Posaconazole (Noxafil): tablets and oral suspension not interchangable

Different dosage forms of posaconazole should not be substituted for each other

Read more
  • 31 May 2016 - Drug Updates

Interim measures following signal of serious infection and mortality associated with idelalisib (Zydelig▼)

New interim treatment recommendations for idelalisib for chronic lymphocytic leukaemia and follicular lymphoma

Read more